Last reviewed · How we verify

NCT03977298

Surgical Protocol for Peri-Implantitis Treatment-4

Status unknown NA Last updated 3 November 2020
What this trial tests

NA trial testing Chlorhexidine in Peri-Implantitis in 30 participants. Status unknown.

Timeline
2 July 2018
Primary endpoint
30 December 2021
30 December 2021

Quick facts

Lead sponsorUniversità Vita-Salute San Raffaele
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date2 July 2018
Primary completion30 December 2021
Estimated completion30 December 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Università Vita-Salute San Raffaele — full company profile →

Who can join

Adults 18 to 100, any sex, with Peri-Implantitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Peri-implant diseases are common post-restorative complications in implant rehabilitations and they occur with an incidence of 12-43%. Based on the available data in literature, the surgical therapy for peri-implantitis is effective in disease resolution. Surgical access to peri-implant lesions facilitates the removal of all granulation tissue from the defect area as well as debridement and decontamination of the exposed implant surface defect area. Different techniques have been used for implant surface decontamination during peri-implant surgery, including mechanical, chemical and laser treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Chlorhexidine

Trials testing the same drug.

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

Other Università Vita-Salute San Raffaele trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03977298.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing